HealthcareHealthcare Equipment & SuppliesMedical Equipment & Supplies

Amkay Products Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 16 filings·Updated 1 Oct 2026
Showing 10 of 16 filings.
1 Oct 20261 filing
Company UpdateClarification

The Exchange has sought clarification from Amkay Products Ltd on October 01, 2026, with reference to significant movement in price, in order to ensure that investors have latest relevant ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 19:19
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Amkay Products Limited trading window closed from 01 October 2026 till expiry of 48 hours after the declaration of financial results for the half year ended 30 September 2026

Amkay Products Limited trading window closed from 01 October 2026 till expiry of 48 hours after the declaration of financial results for the half year ended 30 September 2026

Filed 14:12View Source
10 Sept 20261 filing
Company UpdateNewspaper Publication

Newspaper publication for Notice of Annual General Meeting

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 16:04View Source
7 Sept 20261 filing
OthersReg. 34 (1) Annual Report

Amkay Products Limited FY2025-26: Revenue rises; PAT declines; AGM on Sept 30, 2026

Financial highlights

  • Revenue from operations: ₹4,202.70 lakh.
  • Total income: ₹4,269.64 lakh.
  • PAT: ₹231.10 lakh; prior year ₹333.85 lakh.
  • Basic EPS: ₹2.67; Diluted EPS: ₹2.67.
  • Dividend: no dividend declared.
  • Net profit margin: 5.50%.

Revenue mix & segments

  • Manufacturing sales: ₹2,452.66 lakh; Trading sales: ₹1,750.03 lakh.
  • Total segment revenue: ₹4,202.70 lakh.
  • Domestic revenue dominates; exports modest.
  • Inter-segment revenue: nil.

Capital structure & liquidity

  • Paid-up capital: ₹865.56 lakh.
  • Total debt ₹392.53 lakh; equity ₹2637.61 lakh; D/E 0.15x.
  • Current ratio: 3.29x (31-Mar-2026).
  • Cash flow: operating ₹118.48 lakh; net cash increase ₹164.33 lakh.

Governance & controls

  • Board meetings held: 12 during the year.
  • MD and CFO attended all board meetings.
  • 19th AGM on Sept 30, 2026 via VC/OAVM.
  • MD up for reappointment by rotation.
  • Independent directors declare independence; internal controls adequate.

Risk management & compliance

  • Risk management framework in place with ongoing monitoring.
  • CSR not applicable for FY2025-26.
  • Audit flags: no material going concern issues.

Outlook & strategy

  • Strategy: Make in India; broaden product portfolio and distribution.
  • Indian medical devices sector outlook positive; growth in domestic and opportunities abroad.

Auditors & related parties

  • Statutory auditors: M/s. R.K. Jagetiya & Co.
  • Related party transactions on arm's length basis; disclosed in notes.
Filed 17:23View Source
29 Aug 20261 filing
Company UpdateGeneral

Amkay Products clarifies price movement is market-driven and reiterates adherence to SEBI LODR Reg 30

Price movement clarification

  • Share price movement is market-driven; company has no control or knowledge of the reasons.
  • Company will inform BSE of any information as required under Regulation 30 of LODR.
Filed 20:32View Source
28 Aug 20261 filing
Company UpdateClarification

The Exchange has sought clarification from Amkay Products Ltd on August 28, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 18:08
4 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Regulation 74(5) certificate: no dematerialisation requests received for quarter ended 30 June 2026.

Dematerialisation status for quarter ended 30 June 2026

  • Regulation 74(5) not applicable; all shares are in demat form and no dematerialisation requests received during the quarter.
Filed 19:42View Source
27 Apr 20262 filings
OthersFormat of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2

<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 13:08View Source
OthersFormat of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 13:02View Source
25 Mar 20261 filing
Insider Trading / SASTClosure of Trading Window

Intimation for Closure of Trading Window

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 17:00View Source
Showing 10 of 16 filings